48Hour Discovery
48Hour Discovery is a biotechnology company revolutionizing peptide drug discovery through its proprietary phage display platform. Leveraging cutting-edge technology, 48HD rapidly identifies, validates, and optimizes preclinical drug candidates providing an efficient and innovative solution for early-stage drug development. Since its founding in 2017, 48HD has partnered with over 25 companies, including global pharmaceutical leaders, to advance precision medicine and targeted therapies. Ask us about our growing portfolio of potent binders targeting high-value TRP assets.
